Pictet Asset Management (Switzerland)’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,088,359
Closed -$44.7M 1764
2021
Q4
$44.7M Buy
2,088,359
+372,504
+22% +$7.34M 0.04% 360
2021
Q3
$31.7M Buy
+1,715,855
New +$34.5M 0.04% 421

Other funds holding OCDX

Pictet Asset Management (Switzerland)'s OCDX Position: Q1 2022 in Review

Pictet Asset Management (Switzerland) sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q1 2022, closing a stake of 2,088,359 shares — an estimated $44.7M sold.

Pictet Asset Management (Switzerland) first reported a position in OCDX in Q3 2021 and held it in 2 quarters. The position peaked at $44.7M in Q4 2021. 170 funds tracked by Wall St. Rank hold OCDX as of Q1 2022.

  • Pictet Asset Management (Switzerland) reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • Pictet Asset Management (Switzerland) sold 2,088,359 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q1 2022, an estimated $44.7M.
  • Pictet Asset Management (Switzerland) first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q3 2021 and held it in 2 quarters.
  • Pictet Asset Management (Switzerland)'s Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $44.7M in Q4 2021.
  • 170 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q1 2022.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q1 2022, filed 13 May 2022.